Chitosan scaffolds for cartilage regeneration: influence of different ionic crosslinkers on biomaterial properties
Source abstract
Abstract
Chitosan is considered an elective scaffolding material in articular cartilage engineering due to its structural similarity with various Glycosamminogicans found in articular cartilage. Its poor mechanical properties, though, must be enhanced through a crosslinking treatment. Arginine (Arg) and tripolyphosphate (TPP), have been chosen as crosslinking agents, and their influence onto the chemico-physical properties (morphology, mechanical performances and stability behavior) of the resulting chitosan scaffold have been elucidated. The methodological conditions to produce a scaffold for the cartilage regeneration with tunable structural and chemical physical properties have been assessed. Furthermore, this study introduces Arginine as an innovative stabilizing agent.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Polymer Surface Interaction Studies · Silk-based biomaterials and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Dhitech S.c.a.r.l., Lecce, Italy;
Department of Engineering for Innovation, University of Salento, Lecce, Italy;
Ghimas S.p.A., c/o Dhitech S.c.a.r.l., Lecce, Italy;
Department of Biomedicine, University Hospital of Basel, Basel, Switzerland;
Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Neuropathology Unit, Institute of Experimental Neurology, Milan, Italy
Funding
Italian Ministry of University and Research
References (35)
Show source-provided references
1. 10.1177/194173810935043810.1177/1941738109350438 ↗
2. 10.1111/ans.1210810.1111/ans.12108 ↗
3. 10.1007/s11706-013-0188-610.1007/s11706-013-0188-6 ↗
4. 10.1016/j.addr.2007.08.03810.1016/j.addr.2007.08.038 ↗
5. 10.3390/md1211546810.3390/md12115468 ↗
6. 10.1016/j.carbpol.2012.04.05710.1016/j.carbpol.2012.04.057 ↗
7. 10.1016/j.progpolymsci.2011.02.00110.1016/j.progpolymsci.2011.02.001 ↗
8. 10.1016/S0939-6411(03)00161-910.1016/S0939-6411(03)00161-9 ↗
9. 10.1007/s10856-010-4177-310.1007/s10856-010-4177-3 ↗
10. Peppas N. A · 1
11. 10.1016/S0939-6411(03)00160-710.1016/S0939-6411(03)00160-7 ↗
12. 10.3390/pharmaceutics904005310.3390/pharmaceutics9040053 ↗
13. 10.1016/j.addr.2013.04.01610.1016/j.addr.2013.04.016 ↗
14. 10.3844/ajassp.2012.1091.1100.10.3844/ajassp.2012.1091.1100. ↗
15. 10.4236/oalib.110433610.4236/oalib.1104336 ↗
16. 10.1016/j.memsci.2014.03.04410.1016/j.memsci.2014.03.044 ↗
17. 10.1590/S1516-1439201300500005910.1590/S1516-14392013005000059 ↗
18. 10.1016/B978-0-08-100722-8.00019-X10.1016/B978-0-08-100722-8.00019-X ↗
19. 10.1016/j.carbpol.2016.07.12610.1016/j.carbpol.2016.07.126 ↗
20. 10.1016/j.carbpol.2009.01.03610.1016/j.carbpol.2009.01.036 ↗
21. 10.3390/md804130510.3390/md8041305 ↗
22. 10.1016/j.ijbiomac.2013.12.01710.1016/j.ijbiomac.2013.12.017 ↗
23. 10.1016/j.tibtech.2015.03.00810.1016/j.tibtech.2015.03.008 ↗
24. 10.4028/www.scientific.net/KEM.587.24910.4028/www.scientific.net/KEM.587.249 ↗
25. 10.1016/S0142-9612(01)00235-610.1016/S0142-9612(01)00235-6 ↗
26. 10.1002/jbm.a.3286910.1002/jbm.a.32869 ↗
27. 10.1007/s00216-004-2765-010.1007/s00216-004-2765-0 ↗
28. 10.1016/j.colsurfb.2011.09.04210.1016/j.colsurfb.2011.09.042 ↗
29. 10.1016/0022-1759(83)90303-410.1016/0022-1759(83)90303-4 ↗
30. 10.1016/S0032-3861(03)00620-710.1016/S0032-3861(03)00620-7 ↗
31. 10.1007/s11242-016-0689-810.1007/s11242-016-0689-8 ↗
32. 10.1016/j.carres.2005.07.02210.1016/j.carres.2005.07.022 ↗
33. 10.1021/mp300162j10.1021/mp300162j ↗
34. 10.1186/1423-0127-16-6510.1186/1423-0127-16-65 ↗
35. 10.1039/C7RA02842C10.1039/C7RA02842C ↗